
Ballard Spahr says the Hikma v. Amarin decision makes it harder for brand-name drugmakers to sue over "skinny label" generics — a shift likely to speed generic competition and lower costs for patients
A recent study provides insight into public opinions about healthcare.
Healthcare can be both costly and confusing to the average consumer. Maestro Health, an employee health and benefits company, conducted a survey to gauge consumer opinions on navigating healthcare, price transparency, and financial strain.Here are the key findings:





